# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JP Morgan analyst Lisa Gill maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $101 to $86.
Baird analyst Michael Ha initiates coverage on CVS Health (NYSE:CVS) with a Neutral rating and announces Price Target of $61.
Mass retirement of boomers could have major economic impact. Experts anticipate both risks and opportunities from the largest w...